The company Ranbaxy. Pills

Indian generic company Ranbaxy is one of the largest manufacturers of pharmacological drugs. It is a recognized international firm whose production is based on its own scientific developments. The company produces a wide assortment of high quality medicines and affordable prices for a wide range of consumers.

Ranbaksi's products are popular with patients all over the world. The company's products were presented on the pharmacological market of Russia in the early nineties of the last century. Produced by Ranbaksi tablets "Ketanov" and "Fenyuls", as well as "Zanopin" and "Tsifran" are widely known to many doctors and pharmacists. In the pharmacy chain, their implementation is done without a prescription and occupies one of the leading places among antibiotics and analgesics.

The company produces a wide range of modern medicines used in the field of gastroenterology, in the treatment of heart and vascular diseases, as well as in the course of therapy, which restores metabolic processes in the patient's body. The tablets "Tsifran OD", "Klabaks OD", as well as "Zanotsin OD", related to the group of antibiotics, presented by Ranbaksi in 2000, are the result of a unique scientific development. It allowed to reduce the release rate in the body of the active substance. Currently, the use of the drug "Cyphran OD" is widely practiced to get rid of many existing types of infections.

In the Russian market of medicines, innovative kits "Pilobakt" and "Pylobakt AM" are also presented. Their use is intended for eradication of H-pilori and has high therapeutic efficacy.

Produced by the company Ranbaksi tablets "Ofloxacin", intended for the treatment of tuberculosis, which has a drug-resistant form. To get rid of this pathology, the company also produces infusion of Levofloxacin.

One of the leading places the company occupies as a manufacturer of fluoroquinolone antibiotics.

Beginning in 2000, Ranbaxy offers AIDS pills, which belong to the group of antiretroviral drugs. These medicines have been approved by WHO for mass production. Especially in demand these high-quality and affordable drugs will be in such underdeveloped and developing countries as Africa and Asia, Latin America.

The company supports any program aimed at combating HIV infection by providing the necessary medications. Compliance with modern levels of GMP standard laboratories, production facilities, as well as Ranbaxy's research and development, from which the introduction of drugs on the market is carried out in a fairly short time. This includes both branded and specialized generic medicines.

Generic drugs Ranbaxy, instructions for their use indicate their high therapeutic effect, are constantly updated with new lists. Currently, the company serves patients from one hundred and twenty-five countries. The company is constantly expanding the list of subsidiaries of international type, joint organizations and associations.

Direct activity of the company is carried out in forty six countries, and its production is located in seven states. Occupying a strong position on the world market, the company represents a large number of innovative products. This makes it possible to increase the availability of high-quality and low-cost products.